Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amgen Inc.

Market Cap 182B 265,965B 159B 147B 138B 258B 17,193B 260B 1,745B 676B 8,462B 684B 669B 29,384B P/E 2026 *
21.9x
P/E 2027 * 20x
Enterprise Value 223B 326,151B 195B 180B 169B 317B 21,083B 319B 2,140B 830B 10,377B 839B 821B 36,033B EV / Sales 2026 *
5.91x
EV / Sales 2027 * 5.61x
Free-Float
99.78%
Yield 2026 *
2.99%
Yield 2027 * 3.16%
1 day-0.18%
1 week-4.39%
Current month+1.86%
1 month+2.04%
3 months+0.30%
6 months-0.12%
Current year+1.80%
1 week 16,350
Extreme 16350
17,700
1 month 16,120
Extreme 16120
18,030
Current year 15,920
Extreme 15920
19,280
1 year 10,650
Extreme 10650
19,280
3 years 3,600
Extreme 3600
19,280
5 years 1,280.17
Extreme 1280.1667
19,280
10 years 273.67
Extreme 273.6667
19,280
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 67 01/01/2020
Chief Operating Officer 59 25/07/2016
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-4.39% - - 182B
+0.12%-2.83%+42.40%+139.77% 980B
+0.56%-2.65%+51.60%+38.51% 550B
+4.82%+2.34%+23.41%+65.04% 382B
-0.17%-3.09%+23.33%+16.78% 316B
+0.31%+0.32%+27.08%+14.16% 272B
+1.26%-0.65%+25.62%+32.62% 268B
+1.30%+3.48%-34.42%-45.57% 199B
+0.11%-0.33%+16.67%+58.61% 154B
-0.77%-3.94%+3.93%-35.52% 144B
Average +0.68%-2.59%+19.96%+31.60% 362.65B
Weighted average by Cap. +0.76%-3.45%+29.64%+59.96%

Financials

2026 *2027 *
Net sales 37.78B 55,148B 32.94B 30.51B 28.56B 53.56B 3,565B 53.89B 362B 140B 1,755B 142B 139B 6,093B 38.75B 56,561B 33.78B 31.29B 29.29B 54.93B 3,656B 55.27B 371B 144B 1,800B 145B 142B 6,249B
Net income 8.26B 12,064B 7.21B 6.67B 6.25B 11.72B 780B 11.79B 79.17B 30.68B 384B 31.02B 30.36B 1,333B 9.04B 13,197B 7.88B 7.3B 6.83B 12.82B 853B 12.89B 86.61B 33.56B 420B 33.94B 33.21B 1,458B
Net Debt 41.23B 60,186B 35.95B 33.3B 31.17B 58.45B 3,891B 58.81B 395B 153B 1,915B 155B 151B 6,649B 35.08B 51,210B 30.59B 28.33B 26.52B 49.74B 3,310B 50.04B 336B 130B 1,629B 132B 129B 5,658B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
19/06/26 16,970.00 $ -0.18% 1,210
18/06/26 17,000.00 $ -0.53% 2,987
17/06/26 17,090.00 $ -1.84% 433
16/06/26 17,410.00 $ -1.92% 1,067
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
337.60USD
Average target price
352.77USD
Spread / Average Target
+4.49%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!